Skip to main content

Ellen Kurek

News
04/14/2022
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate...
04/14/2022
Journal of Clinical Pathways
Conference Coverage
06/14/2022
Researchers at the 2022 ASCO Annual Meeting examined the prevalence of prior authorization for PARP inhibitors among patients with ovarian cancer overall, by frontline or recurrent maintenance, and by genetic status.
Researchers at the 2022 ASCO Annual Meeting examined the prevalence of prior authorization for PARP inhibitors among patients with ovarian cancer overall, by frontline or recurrent maintenance, and by genetic status.
Researchers at the 2022 ASCO...
06/14/2022
Journal of Clinical Pathways
News
05/10/2022
The administration of oral etoposide at a dose of 50 mg/m2 showed fairish oncologic outcomes with manageable toxicity among patients with recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
The administration of oral etoposide at a dose of 50 mg/m2 showed fairish oncologic outcomes with manageable toxicity among patients with recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
The administration of oral...
05/10/2022
Journal of Clinical Pathways
News
07/08/2022
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies...
07/08/2022
Journal of Clinical Pathways